Prometheus Laboratories has appointed Joseph Limber president and CEO, the company said this week. Limber, who will also become a director of the company, comes to Prometheus from Aclara BioSciences, where he was president and CEO.

Before joining Aclara, Limber served as president and COO at Praecis Pharmaceuticals, and before that he held senior business development and sales and marketing positions with Sequus Pharmaceuticals, Syntex, and Ciba-Geigy, Prometheus said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.